Most Popular Brands: Zanaflex, Sirdalud Retard
Tizanidine hydrochloride is a skeletal muscle relaxant used for treatment of muscle spasticity. Off label it is used for tension headaches, low back pain, and trigeminal neuralgia.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Stiffness/Spasticity | 351 |
|
|
|
|
34 | |
| Pain | 30 |
|
|
2 | |||
| Other | 20 | 0 | |||||
| Muscle spasms, neck and shoulders | 20 | 0 | |||||
| Muscle Spasms, feet and toes | 17 |
|
2 | ||||
| Calf, feet cramps and muscle spasms | 12 |
|
2 |
See all 454 patients currently taking Tizanidine HCl
Mouse over the table for more information
Top 10 dosages based on patients currently taking Tizanidine HCl. See all 41 dosages ►
| 0.25 2mg as needed | 0.5 2mg as needed | 10 2mg as needed | 1mg as needed | 2 2mg as needed | 2 4mg as needed | 2 mg all the time (24/7) | 2 mg as needed | 2mg as needed | 3 4mg as needed | 4 4mg as needed | 4 mg all the time (24/7) | 4 mg as needed | 4mg as needed | 8 mg as needed | as needed | daily | 4 mg weekly | 1 mcg daily | 1 mg daily | 2 mg daily | 3 mg daily | 4 mg daily | 5 mg daily | 6 mg daily | 8 mg daily | 10 mg daily | 12 mg daily | 14 mg daily | 16 mg daily | 18 mg daily | 20 mg daily | 24 mg daily | 28 mg daily | 30 mg daily | 32 mg daily | 36 mg daily | 40 mg daily | 100 mg daily | 300 mg daily | 600 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
1
|
10
|
3
|
2
|
1
|
3
|
16
|
1
|
4
|
32
|
1
|
1
|
1
|
46
|
1
|
107
|
4
|
21
|
65
|
7
|
44
|
3
|
28
|
8
|
16
|
16
|
1
|
4
|
3
|
1
|
1
|
2
|
2
|
1
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
35 | 41% |
|
|
Doctor's advice
|
19 | 22% |
|
|
Other
|
17 | 20% |
|
|
Side effects too severe
|
16 | 19% |
|
|
Personal research
|
7 | 8% |
|
|
Expense
|
3 | 3% |
|
|
Course of treatment ended
|
1 | 1% |
|
|
Not indicated
|
1 | 1% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 21, 2009.